Cencora (COR) Cash from Investing Activities (2009 - 2026)
Cencora (COR) posted Cash from Investing Activities of -$4.9 billion for Q1 2026, down 1528.69% on a QoQ basis from -$299.3 million in Q4 2025, and down 19.55% year-over-year from -$6.1 billion in Q1 2025.
Cencora (COR) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Cencora's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$4.9 billion for Q1 2026.
- Quarterly Cash from Investing Activities fell 19.55% year-over-year to -$4.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.7 billion (down 19.23% YoY) and the FY2025 annual result came in at -$5.0 billion, down 705.26% from the prior year.
- Cash from Investing Activities was -$4.9 billion for Q1 2026 at Cencora, down from -$299.3 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $143.5 million in Q2 2022 and bottomed at -$4.9 billion in Q1 2026.
- A 5-year average of -$799.8 million and a median of -$234.7 million in 2025 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities jumped 102.54% — and 2025, when it tumbled 2349.21%.
- Cencora's Cash from Investing Activities stood at -$1.5 billion in 2022, then surged by 95.65% to -$65.8 million in 2023, then plunged by 421.34% to -$343.0 million in 2024, then grew by 12.75% to -$299.3 million in 2025, then plunged by 1528.69% to -$4.9 billion in 2026.
- Business Quant data shows COR's Cash from Investing Activities at -$4.9 billion in Q1 2026, -$299.3 million in Q4 2025, and -$321.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 425.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -4.87 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -181.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -63.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -3.21 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 53.93 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -754,000.00 |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -708,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.87 Bn |
| Mar 31, 2026 | -4.87 Bn |
| Dec 31, 2025 | -299.32 Mn |
| Dec 31, 2025 | -299.32 Mn |
| Sep 30, 2025 | -321.94 Mn |
| Sep 30, 2025 | -321.94 Mn |
| Jun 30, 2025 | -234.69 Mn |
| Jun 30, 2025 | -234.69 Mn |
| Mar 31, 2025 | -4.08 Bn |
| Mar 31, 2025 | -4.08 Bn |
| Dec 31, 2024 | -343.04 Mn |
| Dec 31, 2024 | -343.04 Mn |
| Sep 30, 2024 | -241.89 Mn |
| Sep 30, 2024 | -241.89 Mn |
| Jun 30, 2024 | -143.92 Mn |
| Jun 30, 2024 | -143.92 Mn |
| Mar 31, 2024 | -166.49 Mn |
| Mar 31, 2024 | -166.49 Mn |
| Dec 31, 2023 | -65.80 Mn |
| Dec 31, 2023 | -65.80 Mn |